Inventor · disambiguated record
Paul Krenitsky
Also filed as: KRENITSKY PAUL · KRENITSKY PAUL J · KRENITSKY PAUL JOHN
29 granted patents·9 pending applications·362 citations·filing 2005–2024
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0397US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0497US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0597US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0696US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 0796US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 0895US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 0994US8283354B2Quinazolines useful as modulators of ion channelsWILSON DEAN·Filed 2005·Granted Oct 9, 2012·22 cites·39 claims
- 1093US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1193US8865771B2Amides useful as inhibitors of voltage-gated sodium channelsVERTEX PHARMA·Filed 2013·Granted Oct 21, 2014·26 cites·14 claims
- 1293US8519137B2Heteroaryl amides useful as inhibitors of voltage-gated sodium channelsJOSHI PRAMOD·Filed 2008·Granted Aug 27, 2013·40 cites·12 claims
- 1392US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 1492US8389734B2Amides useful as inhibitors of voltage-gated sodium channelsCHEN WEICHUAN CAROLINE·Filed 2008·Granted Mar 5, 2013·31 cites·18 claims
- 1591US11203571B2Sulfonamides as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Dec 21, 2021·8 cites·26 claims
- 1691US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1791US8841483B2Compositions useful as inhibitors of voltage-gated sodium channelsJOSHI PRAMOD·Filed 2007·Granted Sep 23, 2014·27 cites·17 claims
- 1891US8779197B2Aryl amides useful as inhibitors of voltage-gated sodium channelsCHEN WEICHUAN CAROLINE·Filed 2008·Granted Jul 15, 2014·26 cites·12 claims
- 1988US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2086US7928107B2Quinazolines useful as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Apr 19, 2011·9 cites·5 claims
- 2182US7718658B2Quinazolines useful as modulators of ion channelsVERTEX PHARMA·Filed 2005·Granted May 18, 2010·6 cites·33 claims
- 2281US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 2373US7683065B2Pyridines useful as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Mar 23, 2010·2 cites·17 claims
- 2472US7858786B2Pyrimidines and pyrazines useful as modulators of ion channelsVERTEX PHARMACEUTICALS INCOROPATED·Filed 2006·Granted Dec 28, 2010·4 cites·17 claims
- 2571US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2661US8809353B2Quinazolines useful as modulators of voltage gated ion channelsWILSON DEAN·Filed 2008·Granted Aug 19, 2014·0 cites·12 claims
- 2756US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2856US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2956US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3056US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3156US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3256US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3355US7880008B2Heterocycles useful as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Feb 1, 2011·0 cites·11 claims
- 3454US8158637B2Quinazolines useful as modulators of voltage gated ion channelsWILSON DEAN·Filed 2006·Granted Apr 17, 2012·0 cites·18 claims
- 3546US8329702B2Heterocycles useful as modulators of ion channelsWILSON DEAN·Filed 2010·Granted Dec 11, 2012·0 cites·13 claims
- 3645US7705002B2Biaryls useful as modulators of ion channelsVERTEX PHARMA·Filed 2006·Granted Apr 27, 2010·0 cites·21 claims
- 3741US2010249100A1Quinazolines useful as modulators of ion channelsVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 3840US8883781B2Thienopyrimidines useful as modulators of ion channelsFANNING LEV T D·Filed 2007·Granted Nov 11, 2014·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →